An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax. (Q51596869)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 May 2013

Language	Label	Description	Also known as
English	An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.	scientific article published on 7 May 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

B-cell lymphoma

1 reference

based on heuristic

inferred from title

diffuse large B-cell lymphoma

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

René-Olivier Casasnovas

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

5

object named as

Amanda F Cashen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

7

object named as

Hervé Tilly

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Alina Berriolo-Riedinger

3

object named as

Alina Berriolo-Riedinger

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Andrea Gallamini

9

object named as

Andrea Gallamini

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

object named as

Michel Meignan

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

object named as

Alberto Biggi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jean-Pierre de Vera

6

object named as

Pierre Véra

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Barry A Siegel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

7 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

number of pages

9

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

40

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1312-1320

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

https://scigraph.springernature.com/pub.10.1007/s00259-013-2435-6

0 references

Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B-cell lymphoma: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Positron emission tomography with [18F]FDG for therapy response monitoring in lymphoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

PET/CT for therapy response assessment in lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Can the interim fluorodeoxyglucose-positron emission tomography standardized uptake value be used to determine the need for residual mass biopsy after dose-dense immunochemotherapy for advanced diffuse large B-cell lymphoma?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Semi-automated volumetric analysis of lymph node metastases in patients with malignant melanoma stage III/IV--a feasibility study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Interim 18F-fluorodeoxyglucose positron emission tomography in diffuse large B-cell lymphoma: qualitative or quantitative interpretation--where do we stand?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference background.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

[(18)F]FDG PET monitoring of tumour response to chemotherapy: does [(18)F]FDG uptake correlate with the viable tumour cell fraction?

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2435-6

21 January 2018

Interim PET in lymphoma: a step towards standardization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23649463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT

1 reference

https://pubmed.ncbi.nlm.nih.gov/23649463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Integrating PET and PET/CT into the risk-adapted therapy of lymphoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23649463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-013-2435-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23649463%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51596869&oldid=1858428553"